Our Technology Detects Lung Cancer at Its Earliest Stage

LuCED™ Test

Our non-intrusive LuCED™ Test uses AI-powered cancer detection and patented Cell-CT imaging to deliver early detection of lung cancer.

Learn more about our breakthrough technology below.

4 Steps in the LuCED Test

To Ease Your Mind and Continue Living Well

Gathering your sputum sample is simple, easy, and non-intrusive and can be done in the comfort of your own home.

Learn more about how effective this simple test is in early detection of lung cancer from our published studies and blog.

1

Collect
Specimen

Our team only needs 3
deep cough sputum samples to get started with analyzing your cells.

2

Input Samples
into Cell-CT

Our patented prep process removes contaminants and prepares cells to be processed at a requested specificity.

3

Cell-CT Processing

3D-Images of the cells are created allowing for in-depth analysis.

4

LuCED AI

Using the power of AI, we are able to detect abnormalities in the cell which may suggest early stage lung cancer.

VisionGate
Potential

VisionGate’s intellectual property portfolio has comprised over 35 issued patents and 5 patents pending.

For investment opportunities, please contact us to receive our informational memorandum.

visiongate potentional 35 patents 51 billion